Portugal Clinical Studies

Our Services

Support the development and coordination of the collaboration protocol and the corresponding contract between CRSs when participants are referred for clinical research purposes.

Data entry for Case Report Form (CRF)

It allows Data Entry outsourcing for recording clinical study data on the Case Report Form (CRF), ensuring the accuracy and integrity of the collected data.

Feasibility

Allows the submission of support requests for country/site feasibility, analysed by a dedicated team.

Recruitment

Consists in the creation of a digital channel to promote clinical studies. It aims at facilitating the recruitment of participants.

Regulatory Affairs

Involves providing support in identifying applicable legislation and regulations for the study, as well as preparing responses to requests from regulatory authorities.

Strategic Planning and Optimisation

Assist CRSs in developing a strategic vision, creating action plans, and enhancing operational efficiency to enable more effective resource allocation throughout clinical studies.

Support with quality assurance

Provide support and advice in the preparation of contractual and other study documentation to ensure compliance with quality standards.

Soluções Tecnológicas

sistema de gestão de bio repositórios_logo

Biobank Management System

Plataforma Recolha de dados Clinicos_Logo

Clinical Data Collection Platform

sistema de gestão de ensaios clínicos_logo

Clinical Trial Management System (CTMS)

OMOP Converter Platform

Recruitment Platform

Telemedicine Platform

Trusted Research Environment (TRE)

Vendor Neutral Archive (VNA)

Portugal in Numbers

5th POSITION

among 83 countries, in the number of health researchers per million inhabitants.

Source: Global Observatory on Health R&D (August 2025)

27th POSITION

among 140 economies worldwide, in the quality of research centers.

Source: The Global Competitiveness Report (2019)

421

Clinical Trials started in 2024 in Portugal.

Source: 2024 indicator data (Submitted by 27 CICs)

1656

Active Clinical Trials in 2024, in Portugal.

Source: 2024 indicator data (Submitted by 27 CICs)

Fostering excellence and generating impact in clinical research in Portugal

The IC&IB performance indicators represent a strategic milestone for the Clinical Research Centers (CIC) of healthcare units. Developed with the goal of promoting operational efficiency, strengthening the national research network, and positioning Portugal as an international reference in the field of biomedical research, these indicators are an essential tool to enhance the quality and competitiveness of clinical research in the country.

New Clinical Trials Map launched in the EU

The Clinical Trials Information System (CTIS)️ launched on March 3, 2025, a new interactive map that facilitates access to information about clinical trials in the European Union.

This map allows searching for Clinical Trials (CT) that are currently ongoing, by location and medical condition, as well as accessing the investigators' contact details to learn how to participate in the CT.

Agência de Investigação Clínica e Inovação Biomédica

A specialized team, beyond Science

The Portugal Clinical Studies is a platform of the Agency for Clinical Research and Biomedical Innovation, which comprises a dynamic and specialized team dedicated to simplifying and streamlining the processes inherent to your clinical study.

Why Portugal?

Placing Portugal among the most attractive countries for conducting clinical studies in the European Union is the Portuguese government's vision for the field of clinical research. Clinical studies constitute one of the main strategic areas for the development of Health in Portugal.

Collaborative Networks

Come and discover an entire network that supports, conducts, and benefits from clinical studies on a national level.

The Portugal Clinical Studies platform promotes a dynamic collaborative network among the various stakeholders of the clinical research ecosystem — healthcare units, researchers, patient associations, thematic networks, with the aim of strengthening scientific excellence, accelerating innovation, and enhancing the impact of health research.